|
Agios Pharmaceuticals
|
28.17 |
|
-1.13 |
-3.86% |
-1.74% |
2025-04-01 |
|
Alnylam Pharmaceuticals
|
269.07 |
|
-0.95 |
-0.35% |
78.14% |
2025-04-01 |
|
Amgen
|
308.15 |
|
-4.06 |
-1.30% |
8.87% |
2025-04-01 |
|
Arrowhead Research
|
12.71 |
|
-0.03 |
-0.24% |
-51.47% |
2025-04-01 |
|
Tectonic Therapeutic
|
17.83 |
|
0.12 |
0.68% |
16.03% |
2025-04-01 |
|
Biogen
|
133.15 |
|
-3.82 |
-2.79% |
-35.87% |
2025-04-01 |
|
BioMarin Pharmaceutical
|
69.97 |
|
-0.72 |
-1.02% |
-19.39% |
2025-04-01 |
|
Gilead Sciences
|
111.13 |
|
-1.05 |
-0.94% |
54.15% |
2025-04-01 |
|
Incyte
|
60.66 |
|
0.11 |
0.18% |
8.64% |
2025-04-01 |
|
Ionis Pharmaceuticals
|
27.51 |
|
-2.66 |
-8.81% |
-36.02% |
2025-04-01 |
|
Moderna
|
27.24 |
|
-1.11 |
-3.92% |
-74.21% |
2025-04-01 |
|
Novartis
|
98.42 |
|
0.58 |
0.59% |
14.84% |
2025-04-01 |
|
Pfizer
|
24.63 |
|
-0.72 |
-2.84% |
-10.60% |
2025-04-01 |
|
PTC Therapeutics
|
49.33 |
|
-1.64 |
-3.21% |
73.68% |
2025-04-01 |
|
Ultragenyx Pharmaceutical
|
35.59 |
|
-0.62 |
-1.71% |
-23.61% |
2025-04-01 |
|
Regeneron Pharmaceuticals
|
620.26 |
|
-14.82 |
-2.33% |
-36.01% |
2025-04-01 |
|
Sarepta Therapeutics
|
64.35 |
|
0.53 |
0.83% |
-49.33% |
2025-04-01 |
|
Vertex Pharmaceuticals
|
481.46 |
|
-3.47 |
-0.72% |
14.50% |
2025-04-01 |